Somaxon Pharmaceuticals, Inc. Logo

Somaxon Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference

| Source: Somaxon Pharmaceuticals, Inc.

SAN DIEGO, Aug. 27, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that Richard W. Pascoe, Somaxon's president and chief executive officer, will present at Stifel Nicolaus 2012 Healthcare Conference at the Four Seasons Hotel in Boston on Thursday, September 6, at 10:20 a.m. Eastern Time.

A live webcast of the presentation will be available in the Investor Relations section of the company's Web site at The webcast will be accessible following conclusion of the live event and archived for approximately 30 days following the conference.

About Somaxon Pharmaceuticals, Inc.

Headquartered in San Diego, CA, Somaxon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and product candidates to treat important medical conditions where there is an unmet medical need and/or high-level of patient dissatisfaction, currently in the central nervous system therapeutic area. Somaxon's product Silenor, available by prescription in the United States, is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance.

For more information, please visit the company's web site at

The Somaxon Pharmaceuticals logo is available at

Tran Nguyen / CFO
Somaxon Pharmaceuticals, Inc.
(858) 876-6500

Matt Sheldon/ Investor Relations
PondelWilkinson Inc.
(310) 279-5975